Drug recall D-1082-2017
Product
Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-0113-01) and 180 vials per case (NDC 0703-0113-03) Mfd By: Hospira, Inc., Lake Forest, IL 60045 USA, Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA.
Reason for recall
Presence of Particulate Matter: Silicone oil
Lots and codes
Lot #: 560103F, Exp. 01AUG2017
Recall details
- Recalling firm
- HOSPIRA INC, LAKE FOREST, LAKE FOREST, IL
- Quantity
- 56,340 vials
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 26, 2017
- Terminated
- May 11, 2018
Related products
- Hydromorphone Hydrochloride – drug information
- NDC 0703-0113 Hydromorphone Hydrochloride · Hydromorphone Hydrochloride 10 mg/mL · Teva Parenteral Medicines, Inc.
- NDC 0703-0018 Hydromorphone Hydrochloride · Hydromorphone Hydrochloride 10 mg/mL · Teva Parenteral Medicines, Inc.
- NDC 0703-0110 Hydromorphone Hydrochloride · Hydromorphone Hydrochloride 10 mg/mL · Teva Parenteral Medicines, Inc.